Capitalización De Mercado Cambio Fecha
AbbVie USD 403.83B 5.2B 2025-12
Alterity Therapeutics Limited AUD 30M 26M 2026-04
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cipla INR 1.22T 6.47B 2025-12
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 144.67M 7.17M 2025-12
CSL USD 55.89B 20.42B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Incyte USD 19.39B 2.83B 2025-12
Infinity Pharmaceuticals USD 0 0 2026-04
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 500.24B 67.44B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Plus Therapeutics USD 17M 54M 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
TG Therapeutics USD 4.73B 1B 2025-12